Am J Psychiatry 160:1277-1285, July 2003
© 2003 American Psychiatric Association
An 8-Week Multicenter, Parallel-Group, Double-Blind, Placebo-Controlled Study of Sertraline in Elderly Outpatients With Major Depression
Lon S. Schneider, M.D.,
J. Craig Nelson, M.D.,
Cathryn M. Clary, M.D.,
Paul Newhouse, M.D.,
K. Ranga Rama Krishnan, M.D.,
Thomas Shiovitz, M.D.,
Karen Weihs, M.D., and
the Sertraline Elderly Depression Study Group
OBJECTIVE: There have been few placebo-controlled trials of selective serotonin reuptake inhibitors for depressed elderly patients. This placebo-controlled study of sertraline was designed to confirm the results of non-placebo-controlled trials. METHOD: The subjects were outpatients age 60 years or older who had a DSM-IV diagnosis of major depressive disorder and a total score on the 17-item Hamilton Depression Rating Scale of 18 or higher. The patients were randomly assigned to 8 weeks of double-blind treatment with placebo or a flexible daily dose of 50 or 100 mg of sertraline. The primary outcome variables were the Hamilton scale and Clinical Global Impression (CGI) scales for severity and improvement. RESULTS: A total of 371 patients assigned to sertraline and 376 assigned to placebo took at least one dose. At endpoint, the patients receiving sertraline evidenced significantly greater improvements than those receiving placebo on the Hamilton depression scale and CGI severity and improvement scales. The mean changes from baseline to endpoint in Hamilton score were –7.4 points (SD=6.3) for sertraline and –6.6 points (SD=6.4) for placebo. The rate of CGI-defined response at endpoint was significantly higher for sertraline (45%) than for placebo (35%), and the time to sustained response was significantly shorter for sertraline (median, 57 versus 61 days). There were few discontinuations due to treatment-related adverse events, 8% for sertraline and 2% for placebo. CONCLUSIONS: Sertraline was effective and well tolerated by older adults with major depression, although the drug-placebo difference was not large in this 8-week trial.
This article has been cited by other articles:
|
|
|
|
 
A. Qaseem, V. Snow, T. D. Denberg, M. A. Forciea, D. K. Owens, and for the Clinical Efficacy Assessment Subcommittee
Using Second-Generation Antidepressants to Treat Depressive Disorders: A Clinical Practice Guideline from the American College of Physicians
Ann Intern Med,
November 18, 2008;
149(10):
725 - 733.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Gartlehner, B. N. Gaynes, R. A. Hansen, P. Thieda, A. DeVeaugh-Geiss, E. E. Krebs, C. G. Moore, L. Morgan, and K. N. Lohr
Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians
Ann Intern Med,
November 18, 2008;
149(10):
734 - 750.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Lesperance, N. Frasure-Smith, D. Koszycki, M.-A. Laliberte, L. T. van Zyl, B. Baker, J. R. Swenson, K. Ghatavi, B. L. Abramson, P. Dorian, et al.
Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial
JAMA,
January 24, 2007;
297(4):
367 - 379.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. F. Reynolds III, M. A. Dew, B. G. Pollock, B. H. Mulsant, E. Frank, M. D. Miller, P. R. Houck, S. Mazumdar, M. A. Butters, J. A. Stack, et al.
Maintenance treatment of major depression in old age.
N. Engl. J. Med.,
March 16, 2006;
354(11):
1130 - 1138.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. E. Lotrich and B. G. Pollock
Aging and Clinical Pharmacology: Implications for Antidepressants
J. Clin. Pharmacol.,
October 1, 2005;
45(10):
1106 - 1122.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Devanand, N. Juszczak, M. S. Nobler, N. Turret, L. Fitzsimons, H. A. Sackeim, and S. P. Roose
An Open Treatment Trial of Venlafaxine for Elderly Patients With Dysthymic Disorder
J Geriatr Psychiatry Neurol,
December 1, 2004;
17(4):
219 - 224.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. P. Roose, H. A. Sackeim, K. R. R. Krishnan, B. G. Pollock, G. Alexopoulos, H. Lavretsky, I. R. Katz, H. Hakkarainen, and Old-Old Depression Study Group
Antidepressant Pharmacotherapy in the Treatment of Depression in the Very Old: A Randomized, Placebo-Controlled Trial
Am J Psychiatry,
November 1, 2004;
161(11):
2050 - 2059.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. D. Lebowitz
Clinical Trials in Late Life: New Science in Old Paradigms
Gerontologist,
August 1, 2004;
44(4):
452 - 458.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Correction
Am J Psychiatry,
June 1, 2004;
161(6):
1145 - 1145.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. CARROLL
Correction
Am J Psychiatry,
June 1, 2004;
161(6):
1145 - 1146.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. S Schneider
Venlafaxine offers no benefit over sertraline and is less well tolerated in depressed nursing home residents
Evid. Based Ment. Health,
May 1, 2004;
7(2):
47 - 47.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. CARROLL
Sertraline and the Cheshire Cat in Geriatric Depression
Am J Psychiatry,
April 1, 2004;
161(4):
759 - 759.
[Full Text]
|
|
|
|
|
|
|
Other articles noted
Evid. Based Ment. Health,
February 1, 2004;
7(1):
3 - 4.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Other articles noted: 25 Jul 03 to 7 Nov 03
Evid. Based Nurs.,
January 1, 2004;
7(1):
e1 - 1.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Sertraline for Elders with Major Depression -- A Modest Effect
Journal Watch Psychiatry,
September 18, 2003;
2003(918):
14 - 14.
[Full Text]
|
|
|
|
|
|
|
Sertraline for Elders with Major Depression -- A Modest Effect
Journal Watch (General),
August 12, 2003;
2003(812):
4 - 4.
[Full Text]
|
|
|
|
|
|
|
J. Rosack
Psychiatr News,
August 1, 2003;
38(15):
26 - 26.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2003
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
